Date
21 January 2020
Antibiotic resistance: more companies are withdrawing sales reps or incentives in order to limit use, finds report
Writing for the British Medical Journal, Elisabeth Mahase covers the results of the second Antimicrobial Resistance Benchmark. In the article, the author looks at where companies are making progress and where improvements are still needed.
Direct links
The article begins with a quote from Jayasree K Iyer, Executive Director of the Access to Medicine Foundation, calling on governments and the pharmaceutical industry to take the current AMR situation seriously and work together to solve it:
“We’re not asking for a scientific miracle here, we are asking for human intervention.”
The article then dives deep into the results of the 2020 Antimicrobial Resistance Benchmark, covering topics like antibacterial R&D, progress in responsible promotion, and tracking the spread of resistance.